Live Breaking News & Updates on Shipment To University Of Melbourne

PharmAla Continues to Support Clinical Trials as the Foremost Supplier of GMP LaNeo MDMA in AustraliaVANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is pleased to announce that is has issued a shipment of its GMP LaNeo MDMA to Mind Medicine Australia, a charity which see ....

British Columbia , United Kingdom , New South Wales , Nick Kadysh , Shane Morris , Nicholas Kadysh , Vitura Health , Orygen Institute , University Of Melbourne , Shipment To University Of Melbourne , Pharmala Biotech Holdings Inc , Neither The Canadian Securities Exchange , University Of Sydney , Pharmala Continues , Support Clinical Trials , Foremost Supplier , Ala Biotech Holdings , Mind Medicine Australia , Chief Executive Officer , Clinical Trial , Canadian Securities Exchange , Market Regulator , Pharmala Biotech Holdings Inc , Biotechnology Company , Research And Development , Pharmala Biotech Holdings Inc ,